Strategic Collaboration Recent partnership with Curative Biotechnology to manufacture clinical supply of a metformin-based topical ophthalmic formulation demonstrates Sterling's capability and willingness to engage early-stage, high-potential programs.

Full Service Sterling operates as a full-service contract manufacturer with expertise in technology transfers, scale-up, and commercial manufacturing, enabling end-to-end programs from development through supply.

Ophthalmic Capability The focus on ophthalmic topical formulations points to a niche where biotech and pharma clients developing eye therapies can leverage GMP clinical and commercial production.

Mid Market With 11-50 employees and revenue in the $25-50 million range, Sterling offers flexible capacity and personalized service suited to mid-sized biotechs and specialty pharma seeking scalable output.

Regional Footprint Based in Dupo, Illinois, Sterling sits in the Midwest pharma manufacturing cluster, presenting opportunities to win regional contracts and reduce supply chain risk through local operations and proximity to talent.